Pregnancy

Pinnacle Fertility Appoints Dr. Richard Scott to Board of Directors, Signaling Leap Forward in Scientific and Strategic Excellence

SCOTTSDALE, Ariz., June 27, 2025 /PRNewswire/ -- Pinnacle Fertility proudly announces the appointment of Dr. Richard Scott to its Board…

7 months ago

Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays

Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen – as second-tier testHOUSTON, June…

7 months ago

INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent

SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare…

7 months ago

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the…

7 months ago

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or the “Company”, “we”, or…

7 months ago

GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025

GE HealthCare continues to advance precision care in cardiology through innovative molecular imaging solutions to help support early diagnosis, tailored…

7 months ago

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Emrosi™ (DFD-29; 40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) demonstrated efficacy independent…

7 months ago

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared…

7 months ago

Maven Clinic Partners with ŌURA to Bring Data-Driven, Personalized Health Support to Women and Families

Partnership combines Oura's real-time health insights with Maven's virtual care to deliver proactive, connected support and better outcomes from fertility…

7 months ago

New Scientific Research Funding Available to Eliminate Pre-Term Deliveries from Preeclampsia

MELBOURNE, Fla., June 17, 2025 /PRNewswire/ -- The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas…

7 months ago